Hormonal oral contraceptive influence on isolation, Characterization and cryopreservation of mesenchymal stem cells from menstrual fluid

The purpose of the study was to evaluate whether the intake of hormonal oral contraceptive influences the viability of mesenchymal stem cell. Sixteen healthy female volunteers with regular menstrual cycles were invited to participate. Menstrual fluid was collected on the day of maximum flux, and collected cells were analyzed by a minimal standard' for MSC characterization: plastic adherence, trilineage (adipogenic, osteogenic, chondrogenic) in vitro differentiation and a minimalistic panel of markers assessed by flow cytometry (CD731, CD901, CD1051, CD34-, CD45-) using monoclonal antibodies. The participants were divided into two groups: Group 1 - no hormonal contraceptive use; Group 2 - hormonal oral contraceptive use. The median of the menstrual fluid volume was 5.0 and the median number of cells was 5.2x10(6). Median of cell viability was 89.3%. After culture, mesenchymal stem cells increased from 0.031% of the total cells to 96.9%. The cells formed clusters and reached confluence after 15-21days of culture in the first passage. In the second passage, clusters and the confluence were observed after 3days of culture. No difference was observed between the groups. Our data suggest that oral hormonal contraceptive intake maintains the viability of mesenchymal stem cells from menstrual fluid.

Palavras-chave

Stem cell, mesenchymal stromal cells, menstrual fluid, hormonal oral contraception

URI

https://observatorio.fm.usp.br/handle/OPI/33126

Referências

Alcayaga-Miranda F, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0192-0
Alcayaga-Miranda F, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0013-5
Allickson Julie G, 2011, Open Stem Cell J, V3, P4
Azedi F, 2017, MOL BIOL REP, V44, P169, DOI 10.1007/s11033-016-4095-7
Borlongan CV, 2010, STEM CELLS DEV, V19, P439, DOI 10.1089/scd.2009.0340
Deng JL, 2016, ONCOTARGET, V7, P55771, DOI 10.18632/oncotarget.9908
Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905
Farzamfar S, 2017, MOL BIOL REP, V44, P407, DOI 10.1007/s11033-017-4124-1
Gargett CE, 2012, REV ENDOCR METAB DIS, V13, P235, DOI 10.1007/s11154-012-9221-9
Gargett CE, 2010, MOL HUM REPROD, V16, P818, DOI 10.1093/molehr/gaq061
Hida N, 2008, STEM CELLS, V26, P1695, DOI 10.1634/stemcells.2007-0826
Huard J, 2002, GENE THER, V9, P1617, DOI 10.1038/sj.gt.3301816
Khanmohammadi M, 2012, INT J HEMATOL, V95, P484, DOI 10.1007/s12185-012-1067-0
Lagana AS, 2015, EUR J GYNAECOL ONCOL, V36, P495, DOI 10.12892/ejgo2750.2015
Lagana AS, 2018, REPROD SCI, V25, P978, DOI 10.1177/1933719116687661
Lagana AS, 2017, MED HYPOTHESES, V103, P10, DOI 10.1016/j.mehy.2017.03.032
Li Y, 2013, STEM CELLS DEV, V22, P1147, DOI 10.1089/scd.2012.0428
Lin J, 2011, J ZHEJIANG UNIV-SC B, V12, P372, DOI 10.1631/jzus.B1100015
Markowska A, 2017, EUR J MED CHEM, V142, P87, DOI 10.1016/j.ejmech.2017.06.030
Meng XL, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-57
Murphy MP, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-45
Patel AN, 2008, CELL TRANSPLANT, V17, P721
Rossignoli F, 2013, BIOMED RES INT, DOI 10.1155/2013/901821
Schwab KE, 2005, FERTIL STERIL, V84, P1124, DOI 10.1016/j.fertnstert.2005.02.056
Ulrich D, 2013, EXPERT OPIN BIOL TH, V13, P1387, DOI 10.1517/14712598.2013.826187
Vitale SG, 2018, OXID MED CELL LONGEV, DOI 10.1155/2018/7924021
Wang Z, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-016-0458-1
Zemel'ko V I, 2013, Tsitologiia, V55, P101
Zhang MJ, 2009, MED HYPOTHESES, V72, P252, DOI 10.1016/j.mehy.2008.10.021
Zhong ZH, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-15

Coleções

Artigos e Materiais de Revistas Científicas - FM/MOG
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/58
Artigos e Materiais de Revistas Científicas - ODS/03

Página do item completo